JP2014524241A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524241A5
JP2014524241A5 JP2014524112A JP2014524112A JP2014524241A5 JP 2014524241 A5 JP2014524241 A5 JP 2014524241A5 JP 2014524112 A JP2014524112 A JP 2014524112A JP 2014524112 A JP2014524112 A JP 2014524112A JP 2014524241 A5 JP2014524241 A5 JP 2014524241A5
Authority
JP
Japan
Prior art keywords
collagen
functional fragment
nucleic acid
cell
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014524112A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/049553 external-priority patent/WO2013020064A1/en
Publication of JP2014524241A publication Critical patent/JP2014524241A/ja
Publication of JP2014524241A5 publication Critical patent/JP2014524241A5/ja
Pending legal-status Critical Current

Links

JP2014524112A 2011-08-03 2012-08-03 コラーゲン7及び関連する方法 Pending JP2014524241A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161514796P 2011-08-03 2011-08-03
US61/514,796 2011-08-03
PCT/US2012/049553 WO2013020064A1 (en) 2011-08-03 2012-08-03 Collagen 7 and related methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017171852A Division JP2017209117A (ja) 2011-08-03 2017-09-07 コラーゲン7及び関連する方法

Publications (2)

Publication Number Publication Date
JP2014524241A JP2014524241A (ja) 2014-09-22
JP2014524241A5 true JP2014524241A5 (enExample) 2015-07-23

Family

ID=47629706

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014524112A Pending JP2014524241A (ja) 2011-08-03 2012-08-03 コラーゲン7及び関連する方法
JP2017171852A Abandoned JP2017209117A (ja) 2011-08-03 2017-09-07 コラーゲン7及び関連する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017171852A Abandoned JP2017209117A (ja) 2011-08-03 2017-09-07 コラーゲン7及び関連する方法

Country Status (10)

Country Link
US (1) US9676837B2 (enExample)
EP (1) EP2753704A4 (enExample)
JP (2) JP2014524241A (enExample)
KR (1) KR20140054160A (enExample)
CN (2) CN108165593A (enExample)
AU (2) AU2012289916B2 (enExample)
BR (1) BR112014002546A2 (enExample)
CA (1) CA2843896A1 (enExample)
MX (1) MX351565B (enExample)
WO (1) WO2013020064A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2398995C (en) 2000-02-04 2014-09-23 Children's Hospital Research Foundation Lipid hydrolysis therapy for atherosclerosis and related diseases
EP2561069B1 (en) 2010-04-23 2017-03-08 Alexion Pharmaceuticals, Inc. Lysosomal storage disease enzyme
NZ715014A (en) 2010-09-09 2018-10-26 Synageva Biopharma Corp Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
WO2012112681A1 (en) 2011-02-15 2012-08-23 Shire Human Genetic Therapies, Inc. Methods for treating lysosomal acid lipase deficiency
US9040484B2 (en) * 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
JP2017510542A (ja) 2014-01-31 2017-04-13 ファクター バイオサイエンス インコーポレイテッド 核酸生成及び送達のための方法及び製品
AU2015243535A1 (en) * 2014-04-08 2016-11-03 University Of Southern California Polypeptide compositions with Type VII collagen fibronectin Type Ill- like repeats and treatment methods for wound closure and healing
KR102204367B1 (ko) * 2014-07-16 2021-01-19 주식회사 엘지생활건강 피부 주름 개선용 화장료 조성물
EP3543339A1 (en) 2015-02-13 2019-09-25 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
GB201601571D0 (en) * 2016-01-28 2016-03-16 Nordic Bioscience As Collagen type Vll alpha 1 assay
WO2017160636A1 (en) * 2016-03-16 2017-09-21 Shire Human Genetic Therapies, Inc. Methods of purifying collagen 7
CA3033788A1 (en) 2016-08-17 2018-02-22 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
US11384135B2 (en) * 2017-09-22 2022-07-12 Modern Meadow, Inc. Recombinant yeast strains
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
CN109022464A (zh) * 2018-07-02 2018-12-18 西安巨子生物基因技术股份有限公司 重组人源型胶原蛋白的羟基化方法
TWI818166B (zh) * 2019-03-27 2023-10-11 美商菲尼克斯組織修復公司 用於生產膠原蛋白7組合物之系統及方法
GB2597416A (en) 2019-04-12 2022-01-26 Geltor Inc Recombinant elastin and production thereof
US12344572B2 (en) 2019-07-03 2025-07-01 Factor Bioscience Inc. Cationic lipids and transfection methods
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
WO2021150959A1 (en) 2020-01-24 2021-07-29 Geltor, Inc. Animal-free dietary collagen
JP2024508527A (ja) * 2021-03-04 2024-02-27 ジェラテック インコーポレイテッド 培養された動物細胞由来のコラーゲンを用いた材料の製造方法
US20240424065A1 (en) 2021-10-12 2024-12-26 Phoenix Tissue Repair, Inc. Collagen 7 protein replacement therapy
CN117143223B (zh) * 2022-08-23 2024-03-08 山西锦波生物医药股份有限公司 一种生物合成人体结构性材料的制备方法
CN116854807A (zh) * 2023-07-26 2023-10-10 浙江大学 一种重组人源ⅶ型胶原蛋白及其制备方法与应用
CN120137008B (zh) * 2025-03-18 2025-09-26 广东普言生物科技有限公司 一种重组Ⅶ型胶原蛋白Pro.C7及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
AU6181300A (en) * 1999-07-29 2001-02-19 Helix Research Institute Liver cancer-associated genes
US7026463B2 (en) * 1999-08-13 2006-04-11 Matthew Glenn Polynucleotides and polypeptides, materials incorporating them and methods for using them
ES2315244T3 (es) 1999-11-12 2009-04-01 Fibrogen, Inc. Gelatina recombinante en vacunas.
CN1552889A (zh) * 2003-12-18 2004-12-08 四川铭让生物科技有限公司 制备胶原蛋白和胶原多肽的方法及其用途
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
US9040484B2 (en) 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen

Similar Documents

Publication Publication Date Title
JP2014524241A5 (enExample)
JP2016105737A5 (enExample)
AR124871A2 (es) Métodos de fabricación para el control del contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes
JP2015521848A5 (enExample)
An et al. Expression of a functional recombinant human basic fibroblast growth factor from transgenic rice seeds
MX345729B (es) Proteina activadora del ensamblaje (aap) y su uso para la fabricacion de particulas de parvovirus que consisten esencialmente de vp3.
MX2011011215A (es) Polipeptido que degrada carbohidratos y usos del mismo.
MY187542A (en) Carbohydrate degrading polypeptide and uses thereof
JP2014524241A (ja) コラーゲン7及び関連する方法
WO2016092550A3 (en) Methods of producing long acting ctp-modified polypeptides
JP2005120106A5 (enExample)
WO2008114673A1 (ja) ポリペプチドの製造方法
NZ742660A (en) Variants of chymosin with improved milk-clotting properties
FI3418296T3 (fi) Syöpäsoluja sitovat rekombinanttilektiinit, joilla on kasvaimen vastainen aktiivisuus, ja valmistusmenetelmä
MX2010000385A (es) Clon celular para producir la fsh.
CA2863578C (en) Methods and compositions for increasing sialic acid production and treating sialic related disease conditions
WO2013163654A3 (en) Nucleic acids, cells, and methods for producing secreted proteins
EP2644616A8 (en) Method for producing web protein, a fused protein, recombinant dna, an expression vector, a host cell and strain-producers
CN105154462A (zh) 一种利用骨架蛋白Fn3在大肠杆菌体内建立N-糖基化受体蛋白模型的方法
NZ589806A (en) Variant hedgehog-interacting protein (hhip1) and methods and uses thereof
JP2017524366A5 (enExample)
US10294284B2 (en) Method for preparing C1q recombinant protein
CN105154461A (zh) 一种利用骨架蛋白Fn3在大肠杆菌体内建立N-糖基化效率检测受体蛋白模型的方法
JP2015536347A5 (enExample)
RU2018137305A (ru) Способ продуцирования рекомбинантного белка